Management of a Patient With a Medical History of Type 2 Diabetes, Hypertension, and Obesity Recently Diagnosed With Stage 3A CKD

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Novo Nordisk, Inc.

Activity Description

Diabetes is the most common cause of chronic kidney disease (CKD), and diabetes with CKD is often referred to as diabetic kidney disease (DKD). DKD is a serious progressive disease that contributes markedly to the high burden of morbidity or mortality associated with diabetes. In this interactive Curbside Consult, George L. Bakris MD, FAHA, FASN, will moderate a clinical case with an expert, highlighting interventions to address evidence-based therapies in patients with T2D and CKD based on the latest guideline recommendations and clinical data.

Target Audience

The intended audience for this activity is nephrologists and other healthcare professionals involved in the management of patients with T2D and CKD.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Examine evidence-based therapies in patients with T2D and CKD based on the latest guideline recommendations.
• Identify glucagon-like peptide-1 receptor agonists that can be used in individualized management plans for patients with T2D and CKD.

Activity Chair

George L. Bakris, MD, FAHA, FASN
Professor of Medicine
Director, American Heart Association Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, IL

Faculty

Peter Rossing, MD, DMSc
Head of Complications Research Steno Diabetes Center Copenhagen
Herlev, Denmark
Professor of Endocrinology
Department of Clinical Medicine
University of Copenhagen
Copenhagen, Denmark

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This enduring material is approved for 1 year from the date of original release, November 30, 2023, to November 29, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

George L. Bakris, MD, FAHA, FASN
Consultant: AstraZeneca, Bayer, Ionis, Janssen, KBP BioSciences, Novo Nordisk

Peter Rossing, MD, DMSc
Consultant: Astellas, AstraZeneca, Bayer, Boehringer lngelheim, Lilly, Novo Nordisk, Sanofi
Speaker Contracted by Ineligible Company: AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, Novo Nordisk, Sanofi
Independent Research Contractor: AstraZeneca, Bayer, Novo Nordisk

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com